Search research articles
Contact Us
Filters
Showing results (71-80 of 274) with videos related to
Page
of 28
Sort By:
The Oncologist
|
April 12, 2014
Caring for one of our own
Lidia Schapira, Lawrence S Blaszkowsky, Barbara J Cashavelly, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2011
Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older
Danielle N Margalit, Harvey J Mamon, Marek Ancukiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2003
Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors
Jeffrey G Supko, Joseph P Eder, David P Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2010
Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker value
Andrew X Zhu, Dan G Duda, Marek Ancukiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors
Anna Berkenblit, Joseph P Eder, David P Ryan, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 31, 2020
Clinical staging in pancreatic adenocarcinoma underestimates extent of disease
Akhil Chawla, Jennifer Wo, Carlos Fernandez-Del Castillo, et al.
The Oncologist
|
June 22, 2005
A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma
Andrew X Zhu, Charles S Fuchs, Jeffrey W Clark, et al.
Clinical Colorectal Cancer
|
June 27, 2006
Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancer
Jeffrey A Meyerhardt, Denise Heseltine, Shuji Ogino, et al.
Cancer
|
July 13, 2002
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma
Charles S Fuchs, Jeffrey W Clark, David P Ryan, et al.
Digestive Diseases and Sciences
|
July 26, 2006
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors
Matthew H Kulke, Bingyan Wu, David P Ryan, et al.
Page
of 28
Search research articles
Search
Showing results (71-80 of 274) with videos related to
Sort By:
Page
of 28
The Oncologist
|
April 12, 2014
Caring for one of our own
Lidia Schapira, Lawrence S Blaszkowsky, Barbara J Cashavelly, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2011
Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older
Danielle N Margalit, Harvey J Mamon, Marek Ancukiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2003
Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors
Jeffrey G Supko, Joseph P Eder, David P Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2010
Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker value
Andrew X Zhu, Dan G Duda, Marek Ancukiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors
Anna Berkenblit, Joseph P Eder, David P Ryan, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 31, 2020
Clinical staging in pancreatic adenocarcinoma underestimates extent of disease
Akhil Chawla, Jennifer Wo, Carlos Fernandez-Del Castillo, et al.
The Oncologist
|
June 22, 2005
A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma
Andrew X Zhu, Charles S Fuchs, Jeffrey W Clark, et al.
Clinical Colorectal Cancer
|
June 27, 2006
Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancer
Jeffrey A Meyerhardt, Denise Heseltine, Shuji Ogino, et al.
Cancer
|
July 13, 2002
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma
Charles S Fuchs, Jeffrey W Clark, David P Ryan, et al.
Digestive Diseases and Sciences
|
July 26, 2006
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors
Matthew H Kulke, Bingyan Wu, David P Ryan, et al.
Page
of 28